Position in NVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,125,007
+$329,664 QoQ
Shares Held
23,467
+8.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#502
of 1,348 holders
Holding Since
Mar 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OAK ASSOCIATES LTD /OH/ holds $89,054,137 across 8 Drug Manufacturers - General names. NVO ranks #8 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
109,731 | $39,735,789 | |
| 2 | NVS |
Novartis AG
|
155,362 | $24,348,332 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
80,646 | $10,188,815 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
129,790 | $7,478,499 | |
| 5 | JNJ |
Johnson & Johnson
|
10,281 | $2,611,065 | |
| 6 | MRK |
Merck & Co., Inc.
|
16,835 | $2,163,297 | |
| 7 | LLY |
ELI LILLY & Co
|
1,170 | $1,403,333 | |
| 8 | NVO |
Novo Nordisk A S
This page
|
23,467 | $1,125,007 |
All Filings in NVO
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,125,007 | 23,467 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $795,343 | 21,642 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,101,144 | 21,642 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $909,703 | 16,394 | Shares | Sole | 2025-11-12 | |
| 2024-12-31 | $798,523 | 9,283 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,105,326 | 9,283 | Shares | Sole | 2024-11-12 | |
| 2020-12-31 | $2,023,205 | 28,965 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,253,697 | 32,460 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,125,480 | 32,460 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $3,084,648 | 51,240 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||